#Cancer26

31 Mar 2026

Protein sensor lets MRI detect molecular activity

Researchers developed a genetically encoded protein sensor, called MAPPER, that makes molecular activity visible to MRI by changing water movement in cells. The modular system could let scientists image processes like cancer and inflammation continuously in animals.

Read

Photo by Accuray, Unsplash

28 Mar 2026

Alternative medicine linked to lower breast cancer survival

A Yale analysis found that patients who used only complementary and alternative medicine had much lower survival for breast cancer. Combining alternative and traditional care was also linked to worse outcomes.

Level

Read

26 Mar 2026

Blood test in dogs may predict lymphoma response

Researchers studied blood samples from dogs with diffuse large B-cell lymphoma and found gene activity patterns that can predict treatment response. A simple blood test may help guide treatment choices in dogs and possibly humans.

Level

Read

25 Mar 2026

Some chemotherapy drugs trigger immune attack by mimicking viruses

New research finds that some chemotherapy agents can make cancer cells behave like virus‑infected cells. This viral mimicry activates the innate immune system and could let doctors use lower drug doses with better results.

Level

Read

17 Mar 2026

Exercise helps reduce 'chemo brain' during chemotherapy

Researchers tested a home exercise program during chemotherapy and found patients who followed it kept daily activity and reported clearer thinking. The trial compared a six-week exercise plan with standard care during treatment.

Level

Read

28 Feb 2026

New oral Listeria vaccine shows promise against colorectal cancer

Researchers report a modified oral vaccine made from Listeria that primes immune cells in the gut and limits tumor growth in mice. The vaccine worked best when combined with immune checkpoint inhibitors and caused few side effects.

Level

Read

28 Feb 2026

Brain pressure can make neurons self-destruct

Researchers found that sustained physical pressure on the brain can trigger neurons to activate self-destruct programs. This irreversible neuron loss may explain sensory, motor and cognitive problems and suggests drug targets.

Level

Read

27 Feb 2026

Common medicines can change immunotherapy

Researchers say everyday prescription and over‑the‑counter medicines may change how well cancer immunotherapy works. They call for better recording of all medicines and more studies to confirm these effects.

Level

Read

27 Feb 2026

Cherry compounds may slow triple-negative breast cancer

Researchers at Texas A&M report that anthocyanins from dark sweet cherries slowed tumour growth and reduced metastasis in mice, and that combining them with chemotherapy helped control tumours. Further research is needed on safety and absorption.

Level

Read

26 Jan 2026

Taurine may fuel leukemia and weaken bone

Researchers report that taurine — an amino acid found in some drinks and supplements — can feed leukemia cells and reduce bone strength in mice. The study links cancer cell metabolism to bone health and calls for more research.

Level

Read

21 Jan 2026

AI helps detect melanoma from skin images

Researchers at the University of Missouri tested artificial intelligence to help detect melanoma from images of skin. They trained models on many pictures and found combined models improved accuracy, aiming to support faster care.

Level

Read

21 Jan 2026

Cancer survivors may age faster

A new study finds that adolescent and young adult cancer survivors show faster biological and brain aging than peers. The research links faster aging to memory and attention problems and tests ways to help survivors.

Level

Read

31 Dec 2025

New modular CAR-T system controls where and when cells attack

Researchers at the University of Chicago created GA1CAR, a modular CAR-T system that uses short-lived Fab fragments to guide and pause tumor targeting. In animal tests the same cells were redirected to different tumors and remained functional.

Level

Read